vimarsana.com

சவுத்தாம்ப்டன் உயிர் மருத்துவ ஆராய்ச்சி மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Nose drops of modified friendly bacteria offer protection against meningitis

Nose drops of modified friendly bacteria offer protection against meningitis A world-first trial has shown that nose drops of modified friendly bacteria protect against meningitis. Led by Professor Robert Read and Dr Jay Laver from the NIHR Southampton Biomedical Research Centre and the University of Southampton, the work is the first of its kind. Together they inserted a gene into a harmless type of a bacteria, that allows it to remain in the nose and trigger an immune response. They then introduced these bacteria into the noses of healthy volunteers via nose drops. The results, published in the journal Science Translational Medicine, showed a strong immune response against bacteria that cause meningitis. Published in

Study investigates 12-month respiratory outcomes in patients hospitalized for COVID-19

Study investigates 12-month respiratory outcomes in patients hospitalized for COVID-19 A new study has shown that most patients discharged from hospital after experiencing severe COVID-19 infection appear to return to full health, although up to a third do still have evidence of effects upon the lungs one year on. COVID-19 has infected millions of people worldwide. People are most commonly hospitalized for COVID-19 infection when it affects the lungs - termed COVID-19 pneumonia. Whilst significant progress has been made in understanding and treating acute COVID-19 pneumonia, very little is understood about how long it takes for patients to fully recover and whether changes within the lungs persist.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.